• Priority Review of Drug Submissions (Therapeutic Products)
• Clinical trials and drug safety
• Improving the regulatory review of drugs and devices: Expanding priority review pathways …
• Draft guidance on management of rolling reviews for drug submissions: Rolling review …
• Notice to Stakeholders: Statement on the Investigational Use of Marketed Drugs in …